Related Experiment Videos
Human immunodeficiency virus-associated dementia: an evolving disease
Justin C McArthur1, Norman Haughey, Suzanne Gartner
1The Johns Hopkins University, HIV Neurology Program, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-7609, USA. jm@jhmi.edu
Journal of Neurovirology
|April 23, 2003
Summary
This review covers the evolving epidemiology of HIV-associated dementia (HAD). It discusses how highly active antiretroviral therapy (HAART) impacts dementia patterns and explores current therapeutic strategies for managing HAD.
Area of Science:
- Neuroscience
- Infectious Diseases
- Public Health
Background:
- Human Immunodeficiency Virus (HIV) infection can lead to neurological complications, including dementia.
- The advent of highly active antiretroviral therapy (HAART) has significantly altered the course of HIV infection and its associated comorbidities.
- Understanding the changing landscape of HIV-associated dementia (HAD) is crucial for effective patient management.
Purpose of the Study:
- To review the current epidemiology of HIV-associated dementia.
- To describe the evolving patterns of dementia in the context of HAART.
- To discuss therapeutic interventions for HAD.
Main Methods:
- Literature review of epidemiological studies on HAD.
- Analysis of current concepts regarding dementia presentation in treated HIV patients.
- Synthesis of available therapeutic strategies for HAD.
Main Results:
- The epidemiology of HAD has shifted with the widespread use of HAART.
- Dementia patterns in HIV-infected individuals are influenced by HAART, with potential changes in presentation and progression.
- Various therapeutic approaches are being investigated and utilized for managing HAD.
Conclusions:
- HAART has modified the epidemiology and clinical presentation of HIV-associated dementia.
- Continued research into therapeutic aspects is essential for improving outcomes in HAD.
- A comprehensive understanding of HAD's changing nature is vital for clinical practice.